Key Insights

Highlights

Treatment Research

1 treatments under study, led by Schroth

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06907914Not ApplicableRecruiting

Schroth and Scapular Muscle Activation in Hyperkyphosis

Showing all 1 trials

Research Network

Common Treatments

  • Schroth1

Active Sponsors

  • Istanbul University - Cerrahpasa1

Top Investigators

Related Conditions

  • Exercise Therapy1
  • Hyperkyphosis Adolescent1
  • Muscle Activation1

Activity Timeline